Glaucoma Eye Diseases Glaucoma
Conditions
Interventions
Patients will be treated with SLT 2 and randomly divided to treatment in adjacent place (classically treated) or in the same place. Then will be checked at 1 month, 3 months, 6 months and 12 months af
Sponsors
St Eriks Eye Hospital (Sweden)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients suffering from glaucoma or Ocular Hypertenstion (OHT) 1.1. Primary open angle glaucoma (POAG) - open angle defined as > grade II (Shaffer classification: scale 0-IV) assessed by gonioscopy 1.2. Pigmentary and pseudoexfoliative glaucoma 1.3. OHT to be treated with SLT 2 both with and without eye-drops. 2. If both eyes must be treated just one will be selected at random. 3. Older than 18 years, no upper age limit 4. Men and women
Exclusion criteria
Exclusion criteria: 1. Patients treated with cortisone or immunosuppressive drugs 2. Patients suffering from ocular or systemic inflammatory diseases 3. Patients with Possner-Schlossman syndrome 4. Patients that cannot be treated with SLT due to eye?s characteristics (shallow anterior chamber) or bad collaboration
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IOP after repeated SLT in the same area against repeated SLT treatment in adjacent areas. IOP will be measured with the Goldmann applanation tonometry (GAT) at base line (before treatment) and then 1, 3, 6 and 12 months after treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Gender?s influence on IOP 2. Age?s influence on IOP 3. Pseudoexfoliation?s influence on IOP 4. Inflammation measurements using a slit-lamp and according to the international classification of the Standardization of Uveitis Nomenclature (SUN) Working Group | — |
Countries
Sweden
Outcome results
None listed